Search results

Update on Nuclear medicine production at ANSTO.

ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.

A site for the National Radioactive Waste Management Facility has been acquired, with the new facility to be built near the town of Kimba on the South Australian Eyre Peninsula. 

ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.

The Australian Government recently announced $30 million to design a new world-leading nuclear medicine manufacturing facility at ANSTO’s Lucas Heights campus, and replace and an ageing facility.

Seven of Australia’s top nuclear medicine professionals have been briefed on ANSTO’s plans to manage radioactive waste, as well as to support nuclear medicine innovation in Australia.

Commitment to undertake health research.

The physics and chemistry used at ANSTO is built upon, in significant part, by pioneering female scientists who were sidelined, expelled, or simply not credited appropriately for their achievements.

In January 2026, Mr Michael Quigley AM, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry and Innovation, and Minister for Science.

Consultant appointed to consider a variety of financial, manufacture and import options.

In April 15, 1953, Australia entered the nuclear science arena, when the Atomic Energy Act came into effect. The Australian Atomic Energy Commission (AAEC) followed and in 1987 the AAEC evolved into the Australian Nuclear Science and Technology Organisation (ANSTO) as it’s known today.

ANSTO will make an application to the independent nuclear regulator, ARPANSA, to vary its license for its Interim Waste Store. The original operating license was approved in 2015, enabling the facility to hold what is called a TN-81 cask of intermediate-level radioactive waste that was safely repatriated from France in 2015.

Congress marks watershed moment for nuclear medicine and ANSTO

The ANSTO Science Series is a live and virtual meet-up that focuses on the key capacities of ANSTO’s people, partners and facilities and how they are meeting global challenges in sustainable industries, medicine, advanced manufacturing and in accelerating small business.

ANSTO is a highly regulated organisation. Our governance system and processes provide critical guidance to effectively manage ANSTO’s activities. This section outlines the processes and systems that are in place to provide assurance to Government, our stakeholders and the community that we are working within our regulated and mandated requirements.